North American Microfluidics Market Research Report
- Report Code: MI 1001
- Publish Date: Upcoming
The North American Microfluidics Market is mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, cardiovascular diseases, brain disorders and sleep disorders. This market was valued at $669 million in 2013 and is poised to reach $1496 million by 2018, at a CAGR of 17.4%.
The report “North American Microfluidics Market forecast, 2012-2018” analyzes the market segmentation by type such as polymer-based materials, glass-based materials, silicon-based materials, and other materials based microfluidics. All these segments experienced a positive growth till 2018 with an increased awareness for procedures and sophisticated diagnostic techniques.
North America commands the largest share of the microfluidics materials market, followed by Europe and Asia. The North American polymer-based materials segment accounts for the largest share of around 71% of the microfluidics materials market and was valued at $457 million and is expected to reach $1144 million by 2018, at a CAGR of 20.1%, for the given period. The North American glass-based materials market accounts for the share of around 21% of the North American microfluidics materials market. It is expected to reach a CAGR of 11.8%, for the given period. The North American silicon-based materials market accounts for the share of around 9% of the North American microfluidics materials market. It is expected to reach a CAGR of 9.4%, for the given period.
North America commands the largest share of the microfluidics materials market. It was estimated to be $669 million in 2013 and is expected to reach $1.5 billion by 2018 at a CAGR of 17.4%. This large share is due to the presence of a large number of major manufacturers such as Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences (Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.).
Major factors driving growth of the market are increasing number of investments, lower material costs, and large number of local startup companies in countries such as U.S. and Canada
The report also provides an extensive competitive landscaping of companies operating in Biomaterials market. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)
Products and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of Multiple Sclerosis , Epilepsy, Cancer, cardiovascular diseases, and Diabetes
- Country specific Patient pool of Multiple Sclerosis , Epilepsy, Cancer, cardiovascular diseases, and Diabetes
- Country specific Mortality rate of Multiple Sclerosis, Epilepsy, Cancer, cardiovascular diseases, and Diabetes
- Country specific Incidence of Multiple Sclerosis, Epilepsy, Cancer, cardiovascular diseases, and Diabetes
- Disease progression (Pattern analysis)
Procedure Volume Data
- In terms of volume, Cancer and Multiple Sclerosis procedures in each country
Surgeons / Physicians Perception analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Pattern analysis of usage of Polymer-based materials, glass-based materials, silicon-based materials, and other materials based microfluidics by Physicians
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Pricing Trends
- Cost analysis of Polymer-based materials, glass-based materials, silicon-based materials in major countries
- Cancer and Multiple Sclerosis procedures procedural investments in major countries
Competitive Intelligence
- The company share analysis of microfluidics market top players in the North American region
- The crucial developments and strategies of companies in the portfolio of microfluidics market
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Microfluidics-North America, By Materials
4.1 Microfluidics-Polymers-North America
4.2 Microfluidics-Glass-North America
4.3 Microfluidics-Silicon-North America
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
